Cell Isolation Market

Cell Isolation Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells), By Cell Source, By Technique, By Application, By Region - Industry Forecast 2024-2031

Report ID: SQMIG35H2298 | Region: Global | Published Date: November, 2024
Pages: 188 | Tables: 149 | Figures: 73

Cell Isolation Market Competitive Landscape

An exemplary example of a strategic partnership in the cell isolation market is the collaboration between Thermo Fisher Scientific and Nantoomics. Thermo Fisher Scientific, a provider of lab equipment and reagents, partnered with the NantOmics, a company specializing in the genomic and the transcriptomic technologies. The strategic alliance focuses on Thermo Fisher's cell isolation technologies integrating NantOmics' advanced omics platforms and analysis.

Top Player’s Company Profiles

  • Danaher Corporation 
  • Merck KGAA 
  • Thermo Fisher Scientific Inc. 
  • BD 
  • Sartorius AG 
  • Agilent Technologies, Inc. 
  • Bio-Rad Laboratories, Inc. 
  • Qiagen 
  • F. Hoffmann-La Roche Ltd. 
  • Revvity 
  • Lonza 
  • Bio-Techne 
  • Terumo Corporation 
  • Miltenyi Biotec 
  • Takara Bio Inc. 
  • Genscript 
  • Standard Biotools 
  • Alfa Laval 
  • Promega Corporation 
  • Cell Signaling Technology, Inc. 
  • Micareo Inc. 
  • Applied Cells Inc. 
  • Stemcell Technologies 
  • Creative Bioarray 
  • Proteintech Group, Inc. 
  • Magbio Genomics, Inc. 
  • Akadeum Life Sciences 
  • Pluriselect Life Science Ug (Haftungsbeschränkt) & Co. KG 
  • Invent Biotechnologies, Inc.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cell Isolation Market size was valued at USD 4.2 billion in 2022 and is poised to grow from USD 4.74 billion in 2023 to USD 12.42 billion by 2031, growing at a CAGR of 12.80% during the forecast period (2024-2031).

An exemplary example of a strategic partnership in the cell isolation market is the collaboration between Thermo Fisher Scientific and Nantoomics. Thermo Fisher Scientific, a provider of lab equipment and reagents, partnered with the NantOmics, a company specializing in the genomic and the transcriptomic technologies. The strategic alliance focuses on Thermo Fisher's cell isolation technologies integrating NantOmics' advanced omics platforms and analysis. 'Danaher Corporation ', 'Merck KGAA ', 'Thermo Fisher Scientific Inc. ', 'BD ', 'Sartorius AG ', 'Agilent Technologies, Inc. ', 'Bio-Rad Laboratories, Inc. ', 'Qiagen ', 'F. Hoffmann-La Roche Ltd. ', 'Revvity ', 'Lonza ', 'Bio-Techne ', 'Terumo Corporation ', 'Miltenyi Biotec ', 'Takara Bio Inc. ', 'Genscript ', 'Standard Biotools ', 'Alfa Laval ', 'Promega Corporation ', 'Cell Signaling Technology, Inc. ', 'Micareo Inc. ', 'Applied Cells Inc. ', 'Stemcell Technologies ', 'Creative Bioarray ', 'Proteintech Group, Inc. ', 'Magbio Genomics, Inc. ', 'Akadeum Life Sciences ', 'Pluriselect Life Science Ug (Haftungsbeschränkt) & Co. KG ', 'Invent Biotechnologies, Inc.'

One of the major drivers of the cell isolation market is the growing prevalence of chronic diseases, especially cancer. As the incidence of cancer increases worldwide, so the demand for advanced research and treatment solutions also increases. Cell isolation plays an important role in cancer research by enabling researchers to study specific cell types, enabling the development of targeted therapies and personalized drug delivery. Isolated cells gain valuable insights into tumor biology, drug resistance and immunity, helping scientists develop more effective treatments. In addition, the need for more advanced therapies, such as immunotherapy, is also increasing, further increasing the demand for cell ablation techniques. This catalyst is a key driver of growth and innovation in the cell isolation market as research institutes, biotech companies and pharmaceutical companies seek to enhance their efforts in the development of new treatments for chronic diseases and cancer.

North America dominated the global market and had the largest revenue share of 39.8% in 2023. This is due to the presence of well-established pharmaceutical and biotechnology industries. This is due to a significant increase in the number of patients with chronic diseases, government funding for cancer research, growth in the pharmaceutical and biotech sector. Besides, increasing incidence of diseases, new methods of cell extraction an isolate, a growing number of research centers and laboratories. Furthermore, the high prevalence of the chronic infectious diseases, including the COVID-19 outbreak, has led to an increased demand for cell-derived drugs for research and therapeutic purposes.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Cell Isolation Market

Report ID: SQMIG35H2298

$5,300
BUY NOW GET FREE SAMPLE